Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards



Rating:

Share or cite this content

Citations should be made in the following way:
Heikki Ekroos (Kerava, Finland), Heikki Ekroos, Kirsi Kautiainen, Mikko Puhakka, Helena Liira, Juha Laine, Kari Linden, Jarmo Hahl. Cost effectiveness of retreatment with varenicline compared to other commonly used smoking cessation interventions. Eur Respir J 2015; 46: Suppl. 59, 284

Member's Comments

No comment yet.

Related content which might interest you: Bupropion together with cognitive-conductual therapy (CBT) is an alternative for a long-term abstinence of smoking Source: Annual Congress 2013 –Smoking cessation for healthy and non-healthy smokers Year: 2013 Effectiveness and cost-effectiveness of smoking cessation interventions Source: International Congress 2015 – New advances in smoking cessation interventions Year: 2015 Annual budgetary impact of varenicline as part of a smoking cessation strategy in Greece Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards Year: 2015 Costs and benefits accruing from smoking cessation with varenicline Source: Annual Congress 2007 - Smoking cessation Year: 2007 Different types of behavioral interventions for successful smoking cessation Source: Annual Congress 2013 –Smoking cessation Year: 2013 Evaluation of smoking cessation related press coverage in 2014 Source: International Congress 2015 – Smoking cessation Year: 2015 Health benefits and motivators of smoking cessation Source: ERS Course 2015 Year: 2015 Assessing motivation to quit and nicotine dependence in a smoking cessation program- A cross-sectional study Source: International Congress 2015 – Smoking cessation Year: 2015 Cost-effectiveness of varenicline for smoking cessation in the Netherlands Source: Eur Respir J 2007; 30: Suppl. 51, 247s Year: 2007 Effectiveness of pharmacologic therapies on smoking cessation success: Results of three years of smoking cessation clinic Source: International Congress 2014 – Smoking cessation Year: 2014 The cost-effectiveness of smoking cessation interventions. Accounting for medical costs in longer life expectancies Source: Annual Congress 2006 - How to treat tobacco smokers Year: 2006 Medical treatment effectiveness in smoking cessation Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes Year: 2017 Clinical and public health significance of treatments to aid smoking cessation Source: Eur Respir Rev 2008; 17: 199-204 Year: 2008 Evaluation of rate and associated factors with relapse in patients attending smoking cessation programme Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013 Effectiveness of varenicline treatment in a smoking cessation clinic Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation Year: 2009 Smoking cessation guidelines in health and chronic diseases Source: Annual Congress 2006 - PG20 - Smoking cessation in a respiratory medicine setting Year: 2006 Evolution of smoking behavior after early withdrawal of a smoking cessation program Source: Annual Congress 2013 –Smoking cessation for healthy and non-healthy smokers Year: 2013 Nonpharmacological smoking cessation interventions in clinical practice Source: Eur Respir Rev 2008; 17: 187-191 Year: 2008 Half of oral NRT delivered to smoker hospital staff are not use for tobacco cessation but for long term substitution Source: Annual Congress 2013 –Smoking cessation for healthy and non-healthy smokers Year: 2013